Immunome Inc. - Common Stock, par value $0.0001 per share (IMNM)

Historical Holders from Q4 2020 to Q3 2025

Symbol
IMNM on Nasdaq
Type / Class
Equity / Common Stock, par value $0.0001 per share
Shares outstanding
111M
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
91.4M
Holdings value
$1.07B
% of all portfolios
0.003%
Grand Portfolio weight change
+0%
Number of holders
153
Number of buys
89
Number of sells
-53
Average Value change %
+0%
Average buys %
+0.001%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Immunome Inc. - Common Stock, par value $0.0001 per share (IMNM)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
FMR LLC 15% +113% $153M $80.7M 13.1M +112% FMR LLC 30 Sep 2025
T. Rowe Price Investment Management, Inc. 12.2% $125M 10.6M T. Rowe Price Investment Management, Inc. 31 Oct 2025
Redmile Group, LLC 6.2% $45.7M 5.36M Redmile Group, LLC 31 Mar 2025
Point72 Asset Management, L.P. 5.9% $41.6M 4.89M Point72 Asset Management, L.P. 31 Jan 2025
Immunome Aggregator, LP 6% $40.6M 4.77M Immunome Aggregator, LP 31 Jan 2025
Enavate Sciences GP, LLC 4.3% $73.5M 4.77M Enavate Sciences GP, LLC 18 Dec 2025
VANGUARD GROUP INC 5.2% +7.8% $42.1M $14.2M 4.52M +50.7% The Vanguard Group 30 Jun 2025
EcoR1 Capital, LLC 4.7% $34.8M 4.08M EcoR1 Capital, LLC 31 Mar 2025
JANUS HENDERSON GROUP PLC 2.2% -55% $16.3M -$13.1M 1.91M -44.6% JANUS HENDERSON GROUP PLC 31 Mar 2025

Institutional Holders of Immunome Inc. - Common Stock, par value $0.0001 per share (IMNM)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 91.4M $1.07B +$140M $11.71 153
2025 Q2 79.4M $739M +$30.8M $9.30 142
2025 Q1 76.9M $518M +$157M $6.73 141
2024 Q4 53.3M $566M -$37.1M $10.62 119
2024 Q3 51.6M $755M +$58.8M $14.62 114
2024 Q2 47.8M $578M +$107M $12.10 112
2024 Q1 36.6M $904M +$378M $24.68 102
2023 Q4 21.5M $230M +$205M $10.70 57
2023 Q3 2.73M $22.7M +$3.52M $8.35 36
2023 Q2 1.95M $15.4M +$698K $7.91 35
2023 Q1 1.86M $9.34M -$1.2M $4.99 30
2022 Q4 2.1M $4.85M -$694K $2.21 28
2022 Q3 2.3M $10.2M -$14.6K $4.43 23
2022 Q2 2.31M $7.43M -$1.2M $3.21 24
2022 Q1 2.69M $15.4M -$859K $5.68 26
2021 Q4 2.79M $36.4M +$4.81M $12.96 28
2021 Q3 2.39M $58.3M +$6.05M $24.35 31
2021 Q2 2.38M $41.1M +$6.43M $17.30 25
2021 Q1 1.91M $64.7M +$1.32M $33.86 30
2020 Q4 2.01M $19.5M +$19.5M $9.68 24